(RTTNews) - Hanmi Pharm. Co., Ltd. (128940.KS), a South Korean biopharmaceutical and manufacturing company, on Tuesday reported a decline in net income despite higher sales in the third quarter of 2026 compared with the previous year.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。